---
document_datetime: 2025-08-21 15:00:20
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nubeqa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: nubeqa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 9.0516562
conversion_datetime: 2025-12-28 02:34:16.024463
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## NUBEQA

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific information after authorisation (archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Article 61(3) /     | Notification acc.Article61(3)-Accepted | 19/08/2025                          |                                          | PL                              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000291956                     | Update of thepackageleaflet,section6. Contentsof thepack andotherinformation in thesubsection'Manufacturer'the alternativemanufacturerforbatchreleaseis addedtogetherwithextrainformationon how to easily identify each manufacturer per the batch number printed on the carton and on the blister.                                                                                                                                                                                                                                                                                                                 |            |     |
|--------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation typeII / EMA/VR/0000268757 | This was an application for a group of variations. B.II.d.1 Change in the specification parameters and/or limits of the finished product - B.1I.d.1.z Change in the specification parameters and/or limits of the finished product to more accurately describe theappearance of the drugproduct- Accepted B.II.d.2 Change in test procedure for the finished product - B.II.d.2.d Other changes to a test procedure (including replacement or addition)-Accepted B.II.d.2 Change in testprocedurefor the finished product-B.II.d.2.d Other changes to a test procedure (including replacement or addition)-Accepted | 24/07/2025 | N/A |

<div style=\"page-break-after: always\"></div>

|                                          | finished product - B.II.d.2.d Other changes to a test procedure (including replacement or addition)-Accepted B.II.d.1 Change in the specification parameters and/or limits of the finished product - B.II.d.1.e Change outside the approved specifications limits range - Accepted B.11.b.2Change toimporter,batchrelease arrangementsandqualitycontrol testingof thefinishedproduct-B.II.b.2.a Replacementoradditionofasitewhere batch control/testing takes place - Accepted   |            |     |                       |
|------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------|
| Variation type IB / EMA/VR/0000262353    | B.I.a.2 Changes in the manufacturing process of the active substance - B.I.a.2.a Minor change in the manufacturing process of the activesubstance-Accepted                                                                                                                                                                                                                                                                                                                       | 25/04/2025 | N/A |                       |
| Variation type IA_IN / EMA/VR/0000253631 | This was an application for a group of variations. B.II.b.2.cReplacement or addition of a manufacturerresponsibleforimportation and/or batch release-B.I1.b.2.c.1 Not including batch control/testing - Accepted B.II.b.1Replacement or addition of a                                                                                                                                                                                                                            | 11/03/2025 |     | SmPC, Annex II and PL |

<div style=\"page-break-after: always\"></div>

|                                     | manufacturingsiteforpartor all of the manufacturing process of the finished product - B.1I.b.1.b Primary packaging site - Accepted B.II.b.1 Replacement or addition of a manufacturingsiteforpart or all of the manufacturingprocessofthefinished product - B.11.b.1.a Secondary packaging site - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                          |            |     |
|-------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation typeIB/ EMA/VR/0000246083 | This was an application for a group of variations. A. ADMINISTRATIVE CHANGES - A.4 Change in thename and/or address of:a manufacturer(includingwhererelevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate usedinthemanufactureof the active substance(where specified in thetechnical dossier)where noPh.Eur.Certificate of Suitabilityispart of theapproveddossier;or a manufacturer of a novel excipient (where specified in the technical dossier)- Accepted B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in themanufacturingprocessof the active substance orchange in themanufacturer (including where relevant quality control | 14/02/2025 | N/A |

<div style=\"page-break-after: always\"></div>

| testing sites)of the active substance,where no Ph. Eur. Certificate of Suitability is part of the approved dossier - B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediateforAS-Other variation - Accepted B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in themanufacturingprocessof the active substance orchange in themanufacturer (including where relevant quality control testing sites)oftheactive substance,where noPh.Eur.Certificate of Suitability is part of the approved dossier-B.I.a.1.z-Change in the manufacturer of AS or of a starting material/reagent/intermediateforAS-Other variation-Accepted B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in themanufacturingprocessof theactive substance orchangein themanufacturer (including where relevant quality control testing sites)of the active substance,where no Ph. Eur. Certificate of Suitability is part of the approved dossier-B.I.a.1.z-Change in the manufacturer of AS or of a starting material/reagent/intermediateforAS-Other variation - Accepted   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| startingmaterial/reagent/intermediateused in the manufacturing process of the active substanceorchangeinthemanufacturer (including where relevant quality control testingsites)of theactivesubstance,where noPh.Eur.Certificate ofSuitability ispart of the approved dossier -B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS- Other variation - Accepted   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|